Terms: = Brain cancer AND SDHB, PGL4, 6390, ENSG00000117118, SDH1, SDHIP, SDH, IP
279 results:
1. Efficacy and safety of intrathecal pemetrexed for TKI-failed leptomeningeal metastases from EGFR+ NSCLC: an expanded, single-arm, phase II clinical trial.
Fan C; Jiang Z; Teng C; Song X; Li L; Shen W; Jiang Q; Huang D; Lv Y; Du L; Wang G; Hu Y; Man S; Zhang Z; Gao N; Wang F; Shi T; Xin T
ESMO Open; 2024 Apr; 9(4):102384. PubMed ID: 38377785
[TBL] [Abstract] [Full Text] [Related]
2. MRI radiomics for predicting intracranial progression in non-small-cell lung cancer patients with brain metastases treated with epidermal growth factor receptor tyrosine kinase inhibitors.
Qu J; Zhang T; Zhang X; Zhang W; Li Y; Gong Q; Yao L; Lui S
Clin Radiol; 2024 Apr; 79(4):e582-e591. PubMed ID: 38310058
[TBL] [Abstract] [Full Text] [Related]
3. TRIM25 promotes glioblastoma cell growth and invasion via regulation of the PRMT1/c-MYC pathway by targeting the splicing factor NONO.
Chen Y; Xu X; Ding K; Tang T; Cai F; Zhang H; Chen Z; Qi Y; Fu Z; Zhu G; Dou Z; Xu J; Chen G; Wu Q; Ji J; Zhang J
J Exp Clin Cancer Res; 2024 Feb; 43(1):39. PubMed ID: 38303029
[TBL] [Abstract] [Full Text] [Related]
4. A Nomogram and Risk Classification System Predicting the Prognosis of Patients with De Novo Metastatic Breast cancer Undergoing Immediate Breast Reconstruction: A Surveillance, Epidemiology, and End Results Population-Based Study.
Zhao J; Bian S; Di X; Xiao C
Curr Oncol; 2023 Dec; 31(1):115-131. PubMed ID: 38248093
[TBL] [Abstract] [Full Text] [Related]
5. Pan-cancer ion transport signature reveals functional regulators of glioblastoma aggression.
Bahcheli AT; Min HK; Bayati M; Zhao H; Fortuna A; Dong W; Dzneladze I; Chan J; Chen X; Guevara-Hoyer K; Dirks PB; Huang X; Reimand J
EMBO J; 2024 Jan; 43(2):196-224. PubMed ID: 38177502
[TBL] [Abstract] [Full Text] [Related]
6. Connexin 36 Mediated Intercellular Endoplasmic Reticulum Stress Transmission Induces SSTA Resistance in Growth Hormone Pituitary Adenoma.
Wang Z; Lei Z; Wang Q; Jiang Q; Zhang Z; Liu X; Xing B; Li S; Guo X; Liu Y; Li X; Qi Y; Shu K; Zhang H; Huang Y; Lei T
Int J Biol Sci; 2024; 20(2):801-817. PubMed ID: 38169563
[TBL] [Abstract] [Full Text] [Related]
7. RPTOR blockade suppresses brain metastases of NSCLC by interfering the ceramide metabolism via hijacking YY1 binding.
Lin Y; Wu Y; Zhang Q; Tu X; Chen S; Pan J; Xu N; Lin M; She P; Niu G; Chen Y; Li H
J Exp Clin Cancer Res; 2024 Jan; 43(1):1. PubMed ID: 38163890
[TBL] [Abstract] [Full Text] [Related]
8. Local recurrence and metastatic disease in pheochromocytomas and sympathetic paragangliomas.
Araujo-Castro M; García Sanz I; Mínguez Ojeda C; Hanzu F; Mora M; Vicente A; Blanco Carrera C; de Miguel Novoa P; López García MDC; Lamas C; Manjón-Miguélez L; Del Castillo Tous M; Rodríguez de Vera P; Barahona San Millán R; Recasens M; Tomé Fernández-Ladreda M; Valdés N; Gracia Gimeno P; Robles Lazaro C; Michalopoulou T; Álvarez Escolá C; García Centeno R; Barca-Tierno V; Herrera-Martínez AD; Calatayud M
Front Endocrinol (Lausanne); 2023; 14():1279828. PubMed ID: 38155946
[TBL] [Abstract] [Full Text] [Related]
9. An aggressive cabergoline-resistant, temozolomide-responsive macroprolactinoma due to a germline
Alzahrani AS; Bin Nafisah A; Alswailem M; Moria Y; Poprawski D; Al-Hindi H; Pacak K
Front Endocrinol (Lausanne); 2023; 14():1273093. PubMed ID: 38152133
[TBL] [Abstract] [Full Text] [Related]
10. Long-Term Intracranial Outcomes With Combination Dual Immune-Checkpoint Blockade and Stereotactic Radiosurgery in Patients With Melanoma and Non-Small Cell Lung cancer brain Metastases.
Vaios EJ; Shenker RF; Hendrickson PG; Wan Z; Niedzwiecki D; Winter SF; Shih HA; Dietrich J; Wang C; Salama AKS; Clarke JM; Allen K; Sperduto P; Mullikin T; Kirkpatrick JP; Floyd SR; Reitman ZJ
Int J Radiat Oncol Biol Phys; 2024 Apr; 118(5):1507-1518. PubMed ID: 38097090
[TBL] [Abstract] [Full Text] [Related]
11. ZCCHC17 Modulates Neuronal RNA Splicing and Supports Cognitive Resilience in Alzheimer's Disease.
Bartosch AMW; Youth EHH; Hansen S; Wu Y; Buchanan HM; Kaufman ME; Xiao H; Koo SY; Ashok A; Sivakumar S; Soni RK; Dumitrescu LC; Lam TG; Ropri AS; Lee AJ; Klein HU; Vardarajan BN; Bennett DA; Young-Pearse TL; De Jager PL; Hohman TJ; Sproul AA; Teich AF
J Neurosci; 2024 Jan; 44(3):. PubMed ID: 38050142
[TBL] [Abstract] [Full Text] [Related]
12. Responses to systemic therapy in metastatic pheochromocytoma/paraganglioma: a retrospective multicenter cohort study.
Fischer A; Kloos S; Remde H; Dischinger U; Pamporaki C; Timmers HJLM; Robledo M; Fliedner SMJ; Wang K; Maurer J; Reul A; Bechmann N; Hantel C; Mohr H; Pellegata NS; Bornstein SR; Kroiss M; Auernhammer CJ; Reincke M; Pacak K; Grossman AB; Beuschlein F; Nölting S
Eur J Endocrinol; 2023 Nov; 189(5):546-565. PubMed ID: 37949483
[TBL] [Abstract] [Full Text] [Related]
13. Functional analysis of tumor-derived immunoglobulin lambda and its interacting proteins in cervical cancer.
Wang J; Huang J; Ding H; Ma J; Zhong H; Wang F; Chen Y; Peng H
BMC Cancer; 2023 Oct; 23(1):929. PubMed ID: 37784026
[TBL] [Abstract] [Full Text] [Related]
14. DNMT1-mediated regulating on FBXO32 promotes the progression of glioma cells through the regulation of SKP1 activity.
Quan J; Ma C
Environ Toxicol; 2024 Feb; 39(2):783-793. PubMed ID: 37782699
[TBL] [Abstract] [Full Text] [Related]
15. CircRNF10 triggers a positive feedback loop to facilitate progression of glioblastoma via redeploying the ferroptosis defense in GSCs.
Wang C; Zhang M; Liu Y; Cui D; Gao L; Jiang Y
J Exp Clin Cancer Res; 2023 Sep; 42(1):242. PubMed ID: 37723588
[TBL] [Abstract] [Full Text] [Related]
16. The role of neoadjuvant chemotherapy in the management of metastatic central nervous system germinoma: A meta-analysis.
Abu-Arja MH; Shatara MS; Okcu MF; McGovern SL; Su JM; Abdelbaki MS
Pediatr Blood Cancer; 2023 Oct; 70(10):e30601. PubMed ID: 37501569
[TBL] [Abstract] [Full Text] [Related]
17. Efficacy and safety of innate and adaptive immunotherapy combined with standard of care in high-grade gliomas: a systematic review and meta-analysis.
Guo B; Zhang S; Xu L; Sun J; Chan WL; Zheng P; Zhang J; Zhang L
Front Immunol; 2023; 14():966696. PubMed ID: 37483593
[TBL] [Abstract] [Full Text] [Related]
18. SDC1-TGM2-FLOT1-BHMT complex determines radiosensitivity of glioblastoma by influencing the fusion of autophagosomes with lysosomes.
Zeng L; Zheng W; Liu X; Zhou Y; Jin X; Xiao Y; Bai Y; Pan Y; Zhang J; Shao C
Theranostics; 2023; 13(11):3725-3743. PubMed ID: 37441590
[No Abstract] [Full Text] [Related]
19. Efficient neutron capture therapy of glioblastoma with pteroyl-closo-dodecaborate-conjugated 4-(p-iodophenyl)butyric acid (PBC-IP).
Nishimura K; Kashiwagi H; Morita T; Fukuo Y; Okada S; Miura K; Matsumoto Y; Sugawara Y; Enomoto T; Suzuki M; Nakai K; Kawabata S; Nakamura H
J Control Release; 2023 Aug; 360():249-259. PubMed ID: 37356755
[TBL] [Abstract] [Full Text] [Related]
20. SPI1-mediated MIR222HG transcription promotes proneural-to-mesenchymal transition of glioma stem cells and immunosuppressive polarization of macrophages.
Fan Y; Gao Z; Xu J; Wang H; Guo Q; Li B; Li M; Xu H; Qi Y; Zhao S; Qiu W; Pan Z; Wang Q; Xue H; Zhao R; Guo X; Li G
Theranostics; 2023; 13(10):3310-3329. PubMed ID: 37351164
[No Abstract] [Full Text] [Related]
[Next]
